Hyperosmotic exposure of rat hepatocytes triggers epidermal growth factor receptor (EGFR) activation, which results in an activation of the CD95 system and sensitizes the cells toward apoptosis (Reinehr, R., Schliess, F., and Hä ussinger, D. (2003) FASEB J. 17, 731-733). The mechanisms underlying the hyperosmotic EGFR activation were studied. Hyperosmotic exposure (405 mosM) resulted in a rapid activation of the Src kinase family members Yes, Fyn, and Lck. Hyperosmotic Yes, but not Fyn activation, was antioxidant-sensitive and was followed by a rapid Yes/EGFR association. PP-2 abolished the hyperosmotic activation of Fyn and Lck but not activation of Yes and EGFR and their association. However, these latter processes were prevented in the presence of SU6656. SU6656 and antioxidants, but not PP-2 and AG1478, also inhibited the hyperosmotic JNK activation. Cyclic AMP had no effect on hyperosmotic Yes and JNK activation but prevented EGFR/Yes association and EGFR activation in an H89-sensitive way. When the hyperosmolarity-induced Yes-EGFR protein complex started to disappear after 30 min, an association between EGFR and CD95 became apparent, which was followed by CD95 tyrosine phosphorylation and activation. SU6656 but not PP-2 also inhibited EGFR/CD95 association, CD95 tyrosine phosphorylation, CD95 membrane trafficking, and death-inducing signaling complex (DISC) formation. EGFR knockdown had no effect on hyperosmotic Yes activation but prevented CD95 tyrosine phosphorylation, membrane targeting, and DISC formation. Hyperosmotic EGFR and CD95 activation was also largely blunted following Yes knockdown. The data suggest that hyperosmotic signaling triggers an oxidative stress-dependent Yes activation, which is followed by JNK and EGFR activation and subsequent activation of the CD95 system. However, the functional relevance of hyperosmolarity-induced Fyn and Lck activation remains to be elucidated.
Changes in liver cell hydration are important regulators of hepatic metabolism, gene expression, and transport across the plasma membrane through activation of osmosensing and osmosignaling pathways (1) (2) (3) (4) (5) (6) . Hypoosmotic cell swelling involves integrin-dependent osmosensing and osmosignaling via Src kinase and mitogen-activated protein kinases (7, 8) , resulting in an inhibition of autophagic proteolysis and stimulation of bile acid excretion (7, 8) .
Little is known about osmosensing and osmosignaling in response to hyperosmotic hepatocyte shrinkage. Apart from effects on metabolism and gene expression (1) (2) (3) (4) (5) (6) , hyperosmotic hepatocyte shrinkage triggers a rapid translocation of intracellular CD95 to the plasma membrane, which is accompanied by DISC 1 formation and sensitizes hepatocytes toward CD95 ligand (CD95L)-induced apoptosis (9, 10) . Hyperosmotic membrane targeting and activation of CD95 involves rapid activation of the epidermal growth factor receptor (EGFR) and of c-Jun-N-terminal kinases (JNK) (10) , an association of activated EGFR and CD95, and subsequent CD95 tyrosine phosphorylation by the EGFR tyrosine kinase activity. CD95-Tyr phosphorylation is a prerequisite for CD95 membrane trafficking and formation of the death-inducing signaling complex (DISC). The mechanisms underlying the hyperosmotic EGFR activation in hepatocytes has remained unclear, however, the process is antioxidant-and genistein-sensitive, suggestive of the involvement of tyrosine kinases as upstream events (10) .
Recent studies in non-hepatic cell lines point to an activation of the Src kinase family member Fyn by severe hyperosmotic stress, which may result in an increased phosphorylation of caveolin-1 (11) and cortactin (12) . The Src kinase family (for review see Refs. 13 and 14) comprises three ubiquitously expressed members (Src, Fyn, and Yes), which share functional domains such as an N-terminal myristoylation sequence for membrane targeting, SH2 and SH3 domains, a kinase domain, and a C-terminal non-catalytic domain. Recent studies on vascular smooth muscle cells and endothelial cells indicated an involvement of c-Src, but not of Fyn, in the JNK activation in response to oxidative stress (15, 16) . Also oxidative stressinduced activation of Erk-5 in fibroblasts was shown to be Src-, but not Fyn-dependent (17) , whereas Fyn but not Src was required for activation of p90 ribosomal S6 kinase by reactive oxygen species (18) .
The present study was undertaken to identify the putative tyrosine kinase that is involved in hyperosmotic EGFR activation in hepatocytes and to elucidate its role in the proapoptotic action of hyperosmotic hepatocyte shrinkage. The data show that mild hyperosmotic exposure results in an activation of Fyn, Yes, and Lck. Yes, but not Fyn, associates with the EGFR, triggering its activation and, finally, DISC formation. -specific antibody. Total Yes and Fyn, respectively, served as a loading control. To detect phospho-Lck 56 (ϳ56 kDa), phospho-specific antibodies were used. EGFR was immunoprecipitated and detected for tyrosine phosphorylation (ϳ170 kDa) by Western blotting while total EGFR served as a loading control. Representative immunoblots from at least three independent experiments are shown. A, hyperosmolarity induces within 1 min of Yes activation, which was sensitive to SU6656 and NAC, but not to PP-2, herbimycin A, or emodin. B, hyperosmolarity induces after about 15 min of Fyn activation, which was sensitive to SU6656 and PP-2 but not to herbimycin A, emodin, and NAC. C, P-Lck 56 was detectable after 1 min of hyperosmotic exposure and was sensitive to PP-2 and emodin but not to SU6656, herbimycin A, or NAC. D, in line with previous studies (10), hyperosmolarity induced within 1 min EGFR activation, which was sensitive to inhibition by SU6656, but not to PP-2, herbimycin A, or emodin.
EXPERIMENTAL PROCEDURES
Materials-The materials used were purchased as follows: collagenases from Roche Applied Science (Mannheim, Germany); William's E medium from Sigma-Aldrich (Deisenhofen, Germany); penicillin/ streptomycin from Biochrom (Berlin, Germany); fetal calf serum from Invitrogen; Dulbecco's modified Eagle's medium/nut.mix F-12, LipofectAMINE 2000 and pTOPO-TA vector from Invitrogen; TUNEL assay from Roche Diagnostics (Mannheim, Germany). Soluble CD95-ligand (CD95L) was obtained from Alexis Corp. (Grü nberg, Germany) and was always employed with 10-fold amount of enhancer protein (as provided by the supplier). SU6656, PP-2, herbimycin A, emodin, AG1478, and H89 were from Calbiochem. The antibodies used were purchased as follows: rabbit anti-CD95, mouse anti-green fluorescent protein (which cross-reacts with YFP), rabbit anti-FADD and mouse anti-caspase 8 antibodies from Santa Cruz Biotechnology (Santa Cruz, CA); rabbit anti-phospho Lck 56 , rabbit anti-phospho-Src family-Y 418 , and mouse anti-phospho Erk1/2 antibodies from Cell Signaling (Beverly, MA); mouse anti-phospho-Src-Y 418 and rabbit anti-phospho-Src-Y 529 antibodies from Calbiochem; goat anti-rabbit Cy3-conjugated antibody from Dianova (Hamburg, Germany); rabbit anti-phospho-JNK-1/-2 and rabbit anti-phospho-EGFR antibodies from BioSource Int. (Camarillo, CA); rabbit anti-Yes, rabbit anti-Fyn, sheep anti-EGFR, and mouse antiphosphotyrosine antibodies from Upstate Biotechnology (Lake Placid, NY); horseradish peroxidase-conjugated anti-mouse IgG and anti-rabbit IgG from Bio-Rad (Hercules, CA). All other chemicals were from Merck (Darmstadt, Germany) at the highest quality available.
Plasmid Construction-The nucleotide sequence encoding the CD95 receptor was amplified by reverse transcription-PCR using HepG2 mRNA as template with the following primers: 5Ј-GTC GAC CAC TTC GGA TTG CTC AAC-3Ј and 5Ј-CTC TAG ACT AGA CCA AGC TTT GGA TTT C-3Ј. The resulting 1-kb fragment was ligated into the pTOPO-TA vector to proceed pTOPO-TA-CD95. For construction of CD95-YFP, PCR-directed mutagenesis was performed in the template pTOPO-TA-CD95R using the oligonucleotide primers 5Ј-TGC TCG AGA TGC TGG  GCA TCT GGA CCC TCC TAC CT-3Ј and 5Ј-CGG TAC CGT CGA CAC  CAA GCT TTG GAT TTC ATT TCT-3Ј to remove the stop codon of CD95 and introduce a XhoI site on the 5Ј-end and a KpnI on the 3Ј-end. The KpnI-XhoI fragment of CD95 was subsequently inserted into pEYFP-N1 (Clontech, Palo Alto, CA) to create a receptor fusion protein with YFP linked to the C-terminal cytoplasmic tail. The construct was confirmed by sequencing (MWG Biotech, Ebersberg, Germany).
Cell Preparation and Culture-Hepatocytes were isolated from livers of male Wistar rats, which were fed ad libitum with a standard diet, by a collagenase perfusion technique as described previously (9, 10) . Aliquots of 1.5 ϫ 10 6 cells were plated on collagen-coated 6-well culture plates (Falcon, Heidelberg, Germany) and cultured as published recently (9, 10) for 24 h, unless indicated otherwise, before the experiments were started. The viability of the hepatocytes was more than 95% as assessed by trypan blue exclusion.
Human hepatoma cell line 7 (Huh7) cells (19) were cultured in a humidified 5% CO 2 -atmosphere at 37°C in Dulbecco's modified Eagle's medium/nut.mix F-12 supplemented with 10% fetal calf serum and 1% penicillin/streptomycin, resulting in a final osmolarity of 305 mosM as measured using a cryoscopic osmometer (Osmomat 030, Gonotec, Berlin, Germany). Cells were grown to 70% confluency before transient transfection using expression vectors of the CD95-YFP fusion protein supplemented with LipofectAMINE 2000 culture medium without antibiotics. Osmolarity changes were performed by appropriate addition or removal of NaCl from the medium.
Yes and EGFR Protein Knockdown-Antisense oligonucleotides directed to the Src kinase family member Yes or EGFR and the corresponding controls (i.e. nonsense oligonucleotides) were designed and manufactured by Biognostik (Göttingen, Germany). Immediately after hepatocytes were plated on collagen-coated culture plates (Ø 6 cm, Falcon, Heidelberg, Germany) at a density of 4 ϫ 10 6 cells/plate, either 4 M of the respective oligonucleotides (nonsense, Yes-antisense) supplemented with LipofectAMINE 2000 or 2 M of nonsense or EGFRantisense oligonucleotides without cationic lipids, respectively, were instituted according to the manufacturer's recommendations. Thereafter, cells were kept in culture for up to 4 days. In control experiments, uptake of fluorescein isothiocyanate-labeled nonsense oligonucleotides (2 M) was already visible after 1 h of incubation and lasted for up to 4 days.
Western Blot Analysis-At the end of the incubation periods, medium was removed and cells were washed briefly with phosphate-buffered saline and immediately lysed. Samples were transferred to SDS-PAGE, and proteins were then blotted to nitrocellulose membranes using a semi-dry transfer apparatus (Amersham Biosciences) as recently described (9, 10) . Blots were blocked for 2 h in 5% (w/v) bovine serum albumin-containing 20 mM Tris, pH 7.5, 150 mM NaCl, and 0.1% Tween 20 (TBS-T), and then incubated at 4°C overnight with the first antibody (antibodies used: anti-phospho-JNK-1/-2 and anti-phospho-Src family-Y 418 (1:1,000); anti-Yes, anti-Fyn, and anti-phospho-Lck 56 (1: 1,250); anti-phospho-EGFR and anti-phospho-Src-Y 418 and -Y 529 (1: 2,500); anti-EGFR and anti-phospho-Erk-1/-2 (1:5,000); and anti-CD95, anti-FADD, anti-caspase 8, and anti-phospho-tyrosine (all 1:10,000)). Following washing with TBS-T and incubating with horseradish peroxidase-coupled anti-mouse, anti-sheep, or anti-rabbit IgG antibody (all diluted 1:10,000) at room temperature for 2 h, respectively, the blots were washed extensively and developed using enhanced chemiluminescent detection (Amersham Biosciences). Blots were exposed to X-Omat AR-5 film (Eastman Kodak).
Immunoprecipitation-Hepatocytes or Huh7 cells, respectively, were cultured on collagen-coated culture plates (Ø 10 cm; Falcon, Heidelberg, Germany) at a density of 8 ϫ 10 6 cells/plate. They were harvested in lysis buffer containing 136 mM NaCl, 20 mM Tris-HCl, 10% (v/v) glycerol, 2 mM EDTA, 50 mM ␤-glycerophosphate, 20 mM sodium pyrophosphate, 0.2 mM Pefabloc, 5 g/ml aprotinin, 5 g/ml leupeptin, 4 mM benzamidine, 1 mM sodium vanadate, and 1% (v/v) Triton X-100. The lysates were kept for 10 min on ice and then centrifuged at 10,000 ϫ g for 25 min at 4°C, and aliquots were taken for protein determination using the Bio-Rad protein assay (Bio-Rad). The supernatants containing equal protein amounts (200 g) were incubated for 2 h at 4°C with a polyclonal rabbit anti-CD95, rabbit anti-Yes, or rabbit anti-Fyn antibody (dilution 1:100; Santa Cruz Biotechnology, Santa Cruz, CA) to immunoprecipitate CD95, Yes, or Fyn from rat hepatocytes or were incubated for 2 h at 4°C with a monoclonal mouse anti-green fluorescent protein antibody (dilution 1:100; Santa Cruz Biotechnology) to immunoprecipitate the transfected CD95-YFP fusion protein in Huh7 cells, respectively. Then 10 l of protein A-agarose and 10 l of protein-G-agarose (Santa Cruz Biotechnology) was added, and the mixture was Representative blots from three independent experiments are shown. Hyperosmotic exposure led after 5 min to JNK activation, which was sensitive to SU6656, but not to PP-2, emodin, and herbimycin A. Inhibition of the EGFR tyrosine kinase activity using AG1478 or DB-cAMP addition did not affect hyperosmotic-induced JNK activation. incubated at 4°C overnight. Immunoprecipitates were washed three times with a buffer containing 136 mM NaCl, 20 mM Tris-HCl, 10% (v/v) glycerol, 2 mM EDTA, 50 mM ␤-glycerophosphate, 20 mM sodium pyrophosphate, 0.2 mM Pefabloc, 5 g/ml aprotinin, 5 g/ml leupeptin, 4 mM benzamidine, 1 mM sodium vanadate, and 0.1% (v/v) Triton X-100 and then transferred to Western blot analysis as described above. The anti-phospho-Src family-Y 418 antibody was used to detect activating phosphorylation of Yes or Fyn in the respective immunoprecipitates (20) , whereas Yes or Fyn/EGFR association was detected using an anti-EGFR-antibody in the latter samples. EGFR, FADD, and caspase 8 association or tyrosine phosphorylation of the immunoprecipitated CD95 samples were detected by Western blot analysis using the respective antibodies (anti-EGFR, -FADD, -caspase 8, and -phospho-tyrosine).
CD95 Membrane Trafficking-For determination of membrane surface trafficking of CD95 in primary rat hepatocytes, cells were cultured for 24 h on collagen-coated glass coverslips (Ø 30 mm) in 6-well culture plates (Falcon). Permeabilized and non-permeabilized cells were stained as published recently (9, 10), using a polyclonal rabbit anti-CD95 antibody (dilution 1:500 in phosphate-buffered saline) and a secondary anti-rabbit Cy3-conjugated antibody. Cells were visualized using an Axioskop (Zeiss, Oberkochen, Germany), and pictures were taken with a 3CCD camera (Intas, Göttingen, Germany). Receptor membrane trafficking was defined as the appearance of fluorescent spotting on the surface of the non-permeabilized cells compared with the non-permeabilized control cells (9, 10) . For each condition, a blinded observer scored at least 100 cells per independent experiment from at least three different cell preparations for CD95-membrane trafficking.
For determination of membrane surface trafficking of CD95-YFP in Huh7, cells were transfected as described above and plated on glass bottom dishes (Mattek, Ashland, MA). Confocal pictures were taken using the LSM 510 META (Zeiss). YFP was excited with 514 nm. 24 h after transfection CD95-YFP was detected in living cells. At least 100 cells from three independent experiments were counted in a humidified 5% CO 2 -atmosphere at 37°C.
CD95 translocation was also studied by detecting the total CD95 amount in cytosolic and membrane fractions using Western blot analysis. For this, cells were plated on collagen-coated culture plates (Ø 10 cm) at a density of 8 ϫ 10 6 cells/plate and were lysed in a buffer containing 10 mM Tris, 30 mM mannitol, and 10 mM CaCl 2 (pH 7.5). After centrifugation of the samples (5 min, 1,200 ϫ g), the supernatants were subjected to ultracentrifugation (35 min, 40,000 ϫ g) to separate cytosolic from membrane fractions as previously described (9, 10) . The total CD95 amount in the latter fractions was then detected by Western blotting as described above.
Detection of Apoptosis-Terminal deoxynucleotidyl transferase-mediated X-dUTP nick-end labeling (TUNEL) of fluorescein isothiocyanate-conjugated deoxyuridine triphosphate technique was performed as described recently (9, 10) . The number of apoptotic cells was determined by an independent examiner by counting the percentage of fluoresceinpositive cells. At least 100 cells from three independent experiments from three different cell preparations were counted for each condition. Cells were visualized on an Axioskop (Zeiss).
Statistics-Results from at least three independent experiments are expressed as means Ϯ S.E. n refers to the number of independent experiments. Results were analyzed using the Student's t test: p Ͻ 0.05 was considered statistically significant. . Samples were examined after 1 min of hyperosmotic exposure to detect Yes activation, whereas EGFR/Yes association was detected 10 min after institution of hyperosmolarity in Yes immunoprecipitates. Hyperosmotic Yes/EGFR association was sensitive to SU6656, cAMP, N-acetylcysteine, and genistein. C, whereas DB-cAMP (100 M) had no effect on hyperosmotic Yes activation, it abolishes EGFR/Yes association in a H89 (5 M)-sensitive way.
RESULTS

Hyperosmotic Activation of the EGFR Is Triggered by Src Family Kinase Yes in Rat Hepatocytes
the mechanisms underlying hyperosmotic EGFR activation, the role of Src kinase family members was studied. As shown in Fig. 1 , mild hyperosmolarity (405 mosM) led within 1 min to an activation of Yes (Fig. 1A) and Lck (Fig. 1C) , whereas Fyn became activated after 10 -15 min (Fig. 1B) . No significant activation of c-Src was found in response to hyperosmolarity, as assessed by immunoblots for P-Src 418 and P-Src 529 (not shown). In line with previous studies on inhibitor sensitivities of Src kinase family members, hyperosmotic Yes activation was largely abolished in the presence of SU6656 (22) but was insensitive to inhibition by PP-2 (23), herbimycin A (24), or emodin (25) (Fig. 1A) . On the other hand SU6656 and PP-2, but not herbimycin A and emodin inhibited hyperosmotic Fyn activation (Fig. 1B) , whereas hyperosmotic Lck activation was sensitive to PP-2 and emodin, but not to SU6656 or herbimycin A (Fig. 1C) . As shown recently, hyperosmotic exposure of rat hepatocytes activates within 1 min the EGFR (10). Hyperosmotic EGFR activation was prevented by SU6656, whereas PP-2, herbimycin, or emodin were ineffective (Fig. 1D) . The respective time courses as well as the inhibitor profiles for hyperosmotic activation of EGFR and Src kinase family members, respectively, suggest that Yes, but not Fyn or Lck, acts as an upstream kinase in the hyperosmotic EGFR activation. This view is further augmented by the finding that hyperosmotic Yes, but not Fyn or Lck 56 , activation was largely abolished in the presence of N-acetylcysteine (30 mM) (Fig. 1, A-C) , which was recently reported also to prevent hyperosmotic EGFR ac- FIG. 4 . cAMP inhibits hyperosmotic EGFR activation and subsequent CD95 tyrosine phosphorylation and DISC formation. Hepatocytes were cultured for 24 h and then exposed to normoosmotic (305 mosM) or hyperosmotic (405 mosM) medium. When indicated, DBcAMP (100 M) and H89 (5 M) were preincubated for 30 min. CD95 was immunoprecipitated as described under "Experimental Procedures" after the time periods indicated below. The immunoprecipitated CD95 samples were detected for EGFR association (ϳ170 kDa), for tyrosine phosphorylation (CD95-P-Tyr, ϳ48 kDa), for Fas-associated death domain (FADD, ϳ28 kDa) and caspase 8 (Casp8, ϳ54/55 kDa) association by Western blotting. Total CD95 (ϳ48 kDa) served as loading control. Representative blots from at least three independent experiments are shown. Lane 1, EGFR activation. Hyperosmolarity is triggered within 1 min of EGFR activation, which was inhibited by DB-cAMP in an H89-sensitive way. Lane 2, EGFR/CD95 association and subsequent CD95 tyrosine phosphorylation. cAMP has no effect on hyperosmotic CD95/ EGFR association (as detected after 60 min of hyperosmotic exposure), but strongly blunted CD95 tyrosine phosphorylation in an H89-sensitive way. Lane 3, DISC formation. Hyperosmolarity induced within 3 h formation of the death-inducing signaling complex (DISC), as shown by the association of CD95 with FADD and Caspase 8. DISC formation was prevented by cAMP in an H89-sensitive way.
FIG. 5.
Role of Yes in the EGFR-catalyzed activation of the CD95 system. Hepatocytes were cultured for 24 h and then exposed to hyperosmotic medium (405 mosM) for the given time periods. When indicated, SU6656 (10 M), PP-2 (10 M), herbimycin A (1 M), or emodin (50 M) were preincubated for 30 min. Yes, EGFR, and CD95 were immunoprecipitated as described under "Experimental Procedures." Yes immunoprecipitates were detected for CD95 (ϳ48 kDa) and EGFR (ϳ170 kDa) association, whereas EGFR immunoprecipitates were analyzed for tyrosine phosphorylation (P-EGFR, ϳ170 kDa). Immunoprecipitated CD95 samples were detected for Yes (ϳ62 kDa) or EGFR association (ϳ170 kDa), for tyrosine phosphorylation (CD95-PTyr, ϳ48 kDa), for Fas-associated death domain (FADD, ϳ28 kDa) and caspase 8 (Casp8, ϳ54/55 kDa) association by Western blotting. Total CD95 (ϳ48 kDa), total Yes (ϳ62 kDa), or total EGFR (ϳ170 kDa) served as loading controls. Representative blots from at least three independent experiments are shown. A, hyperosmotic Yes/EGFR association precedes EGFR association with CD95. No CD95/Yes association was detectable upon hyperosmotic treatment (lanes 1 and 2) . tivation (10) . Because hyperosmotic exposure of hepatocytes leads to an almost instantaneous N-acetylcysteine-sensitive oxidative stress response, as shown recently by means of dichlorofluorescin diacetate fluorescence measurements (10), the data in Fig. 1 further suggest that hyperosmotic generation of reactive oxygen species is involved in triggering the hyperosmotic activation of Yes but not of Fyn or Lck 56 . Involvement of Yes in Hyperosmotic JNK Activation-As shown in Fig. 2 and in line with previous data (9, 10), hyperosmolarity led within 5-10 min to an activation of c-Jun-Nterminal kinases (JNK). Hyperosmotic JNK activation was strongly blunted in the presence of SU6656 but was insensitive to PP-2, herbimycin A, AG1478, or cyclic AMP (Fig. 2) . Also Yes knockdown (see Fig. 7B below) blunted hyperosmotic JNK activation. These findings suggest that Yes is involved in triggering hyperosmotic JNK activation. In line with this, N-acetylcysteine abolished not only hyperosmotic Yes activation (Fig.  1A) , but also hyperosmotic JNK activation, as shown recently (10) .
Hyperosmotic Yes/EGFR Association and Effect of cAMPCoimmunoprecipitation studies revealed that hyperosmotic exposure results within 1 min in an association of Yes with the EGFR. This association was most pronounced during the first 15 min of hyperosmotic exposure and slowly declined thereafter (Fig. 3A) . No significant association was found between Fyn and the EGFR. Hyperosmotic Yes/EGFR association was inhibited by SU6656, genistein, and N-acetylcysteine (Fig. 3B) , i.e. inhibitors of hyperosmotic Yes activation (Fig. 1A) , whereas PP-2, herbimycin, AG1478, and JNK inhibitor were ineffective. These findings suggest that apparently hyperosmotic Yes activation, but not the EGFR tyrosine kinase activity or JNK, is required for the hyperosmotic Yes/EGFR association.
cAMP inhibited the hyperosmotic Yes/EGFR association but not the hyperosmotic Yes activation (Fig. 3, B and C) . In addition, cAMP had no effect on hyperosmotic JNK, Fyn, and Lck 56 activation (not shown). As further shown in Fig. 3C , inhibition of Yes/EGFR association by cAMP was fully prevented by H89, suggesting transmission of the inhibitory cAMP effect by protein kinase A. Interestingly, and in line with previous data on bile-salt-induced EGFR activation (26, 27) , cAMP also inhibited hyperosmotic EGFR activation in a H89-sensitive way (Fig. 4) . These findings suggest that a physical association of activated Yes with EGFR is required for hyperosmotic EGFR activation.
Role of Yes in the Hyperosmotic Activation of the CD95 System-As shown previously, hyperosmotic exposure of rat hepatocytes leads to membrane trafficking and activation of the CD95 death receptor (9, 10) . This is achieved by a complex process involving a JNK-dependent EGFR/CD95 association and subsequent EGFR-catalyzed CD95 tyrosine phosphorylation, which probably acts as a signal for targeting the EGFR-CD95 complex to the plasma membrane and subsequent re-TABLE I Inhibition of hyperosmotic CD95 membrane trafficking by SU6656, cAMP, and EGFR knockdown A: Hepatocytes were cultured for 24 h, exposed to normo-(305 mosM) or hyperosmolarity (405 mosM) for 3 h and CD95 membrane translocation was detected by immunostaining, as described previously (9, 10). When indicated, SU6656 (10 M), PP-2 (10 M), herbimycin A (1 M), emodin (10 M), DB-cAMP (100 M), or H89 (5 M) were preincubated for 30 min. In line with previous data (9, 10), hyperosmolarity-induced CD95 membrane trafficking (p Ͻ 0.05), which was sensitive to SU6656 and cAMP (p Ͻ 0.05), but not to PP-2, herbimycin A, or emodin (p Ͼ 0.05; not significant (N.S.)). The cAMP-induced inhibition of hyperosmotic CD95 membrane trafficking was inhibited by H89, suggestive for an involvement of PKA. B: Huh7 cells were transfected with CD95-YFP as described under ''Experimental Procedures'' and then exposed to normo-(305 mosM) or hyperosmolarity (405 mosM) for 2 h. Hyperosmolarity-induced membrane targeting of the CD95-YFP construct in Huh7 cells, which was sensitive to SU6656 and cAMP, but not to PP-2. C and D: Hepatocytes were cultured for 96 h with nonsense oligonucleotides, Yes-antisense (C) or EGFR-antisense (D) as described under ''Experimental Procedures'' and stained for CD95 membrane translocation immunocytochemically after 3 h of exposure to normo-(305 mosM) or hyperosmotic (405 mosM) medium. In nonsense oligonucleotide-treated hepatocytes hyperosmolarity induced significant CD95 membrane trafficking compared to normoosmotic control (p Ͻ 0.05). This was largely inhibited by Yes-knockdown (p Ͻ 0.05) or EGFR-knockdown (p Ͻ 0.05), respectively. cruitment of FADD and caspase 8 to CD95 (10) . Thus, the role of hyperosmotic Yes activation for hyperosmotic activation of the CD95 system was studied. As shown in Fig. 5A (lanes 1 and 2) , if at all, only little association between Yes and CD95 was detectable upon hyperosmotic exposure in coimmunoprecipitation experiments. However, the hyperosmolarity-induced EGFR/Yes association (lane 3) started to decrease after 30 min of hyperosmotic exposure, whereas an EGFR-CD95 association was increasingly observed (Fig. 5A, lane 4) . These findings may suggest that Yes dissociates from activated EGFR, when the latter associates with CD95.
As shown in Fig. 5B , hyperosmotic EGFR activation and its association with CD95, as well as CD95 tyrosine phosphorylation and DISC formation, were strongly blunted after Yes inhibition by SU6656, whereas PP-2, herbimycin A, and emodin were ineffective. Likewise, only SU6656, but not the other inhibitors, strongly blunted the hyperosmotic membrane targeting of CD95 in rat hepatocytes (Table I) .
The inhibitory effect of SU6656 but not of PP-2 on CD95 membrane trafficking was also shown in CD95-YFP-transfected Huh7 cells (Table I and Fig. 6 ), which have a fairly low endogenous CD95 expression level (28) . Also these cells exhibit a hyperosmotic Yes activation, which is apparently required for EGFR activation and CD95 tyrosine phosphorylation, as suggested by the SU6656 sensitivity of these processes (not shown). These data indicate that hyperosmotic Yes activation is required for hyperosmotic activation of the CD95 system not only in rat hepatocytes, but also in Huh7 cells.
Also cAMP, which prevents Yes association with the EGFR (Fig. 3C) prevented hyperosmotic CD95 membrane targeting in Huh7 cells in a H89-sensitive way (Table I and Fig. 6 ) as well as CD95 tyrosine phosphorylation and DISC formation in rat hepatocytes (Fig. 4) . Interestingly, as shown in Fig. 4 , cAMP prevented EGFR activation but not its association with the CD95. This is in line with previous data demonstrating that EGFR-CD95 association in response to hyperosmolarity and other pro-apoptotic stimuli such as toxic bile acids and CD95 ligand does not require EGFR activation (21, 27) .
Yes Knock-down Blunts Hyperosmotic EGFR and CD95 Activation-Yes knockdown experiments were performed to confirm the role of Yes in hyperosmotic EGFR and CD95 activation. As shown in Fig. 7 (A and B) , after 4 days of culture a significant decrease in Yes expression was observed, and the hyperosmotic Yes and JNK activation was strongly blunted after Yes knockdown but not after transfection of the nonsense oligonucleotide. Also hyperosmotic EGFR activation was strongly blunted under these conditions (Fig. 7C) , indicating that hyperosmotic JNK and EGFR activation is largely abolished after Yes knockdown. As further shown in Fig. 7C and Table I , Yes knockdown inhibited not only hyperosmotic EGFR activation but also EGFR/CD95 association, CD95 tyrosine phosphorylation, DISC formation, and CD95 membrane trafficking. Yes knockdown also largely abolished the hyperosmotic sensitization of hepatocytes toward CD95 ligand-induced apoptosis, as assessed by the TUNEL technique (Fig. 7D) . Interestingly, Yes knockdown not only prevented the hyperosmotic sensitization toward CD95L-inudced apoptosis, but also decreased the sensitivity of hepatocytes against CD95L-induced apoptosis even under normoosmotic conditions.
Role of EGFR in the Hyperosmotic CD95 Activation-To rule out the possibility that downstream targets of Yes distinct from EGFR trigger the hyperosmotic activation of the CD95 system, EGFR knockdown experiments were performed in rat hepatocytes. As shown in Fig. 8A , after 4 days of culture a significant decrease of EGFR expression was achieved and only a weak Erk signal was obtained in these cells upon addition of epidermal growth factor (Fig. 8B) . The hyperosmotically induced Erk signal, however, was unaffected following EGFR knockdown, indicating that hyperosmotic Erk activation may occur independent from hyperosmotic EGFR activation (Fig. 8B) . Hyperosmotic Yes activation was not affected by the EGFR knockdown, however, downstream events leading to hyperosmotic CD95 activation, such as CD95 tyrosine phosphorylation, membrane targeting, and DISC formation, were largely prevented ( Fig. 8C and Table I ). These findings indicate that Yes-mediated activation of the EGFR is an essential step for hyperosmotic activation of the CD95 system. In line with this, EGFR knockdown also abolished the previously described hyperosmotic sensitization of hepatocytes toward CD95 ligand-induced apoptosis (9) . In line with previous data (9) and using the TUNEL assay as apoptotic readout, much lower CD95L concentrations were required for apoptosis induction in hyperosmotically exposed hepatocytes compared with the normoosmotic control cells (Fig. 8D) . Interestingly, after EGFR knockdown, not only the hyperosmotic sensitization toward CD95 ligand-induced apoptosis was abolished, but EGFR knockdown also strongly inhibited CD95L-induced apoptosis in FIG. 6 . Inhibition of hyperosmotic CD95-YFP membrane trafficking by SU6656 and cAMP. Huh7 cells were transfected with CD95-YFP as described under "Experimental Procedures" and then exposed to normo-(305 mosM) or hyperosmolarity (405 mosM) for 2 h. When indicated, SU6656 (10 M), PP-2 (10 M), cAMP (100 M), or H89 (5 M) was preincubated for 30 min before hyperosmotic exposure. Hyperosmolarity-induced membrane targeting of the CD95-YFP construct was sensitive to SU6656 and cAMP, whereas PP-2 had no effect. For statistical analysis see Table I .
FIG. 7.
Yes knockdown inhibits the hyperosmotic activation of the CD95 system. Src-family kinase Yes protein was knocked down as described under "Experimental Procedures." A, hepatocytes were cultured in cell culture medium (untreated control) or treated with nonsense or Yes-antisense oligonucleotides for the time periods indicated. Total Yes (ϳ62 kDa) was detected by Western blotting. Total CD95 amount (ϳ48 kDa) served as a loading control and for confirmation of specificity of Yes-antisense oligonucleotides. Yes-antisense led within 4 days to a marked decrease in total Yes but not CD95 protein expression. B, in 4 days cultured hepatocytes, Yes knockdown (lane 1) largely prevents hyperosmolarity (405 mosM; stimulation for 1 min; lane 2)-induced Yes and JNK activation (stimulation for 30 min; lane 3) . C, Yes, EGFR, and CD95 were immunoprecipitated as described under "Experimental Procedures" after the time periods indicated below. The immunoprecipitated CD95 samples were detected for EGFR association (ϳ170 kDa), for CD95 tyrosine phosphorylation (CD95-P-Tyr, ϳ48 kDa), for Fas-associated death domain (FADD, ϳ28 kDa) and caspase 8 (Casp8, ϳ54/55 kDa) association with CD95 by Western blotting. Immunoprecipitated Yes and EGFR were detected for activating phosphorylation by Src family-Y 418 (P-Yes-Y 418 , ϳ62 kDa) or tyrosine phosphorylation (P-EGFR, ϳ 170 kDa). Total Yes (ϳ62 kDa), total EGFR (ϳ170 kDa), and total CD95 (ϳ48 kDa) served as loading controls. The amount of CD95 (ϳ48 kDa) was also detected in membrane and cytosolic fractions obtained by ultracentrifugation as described under "Experimental Procedures." Representative blots from at least three independent experiments are shown. Yes knockdown not only abolished hyperosmolarity-induced Yes activation (detected after 1 min of hyperosmotic exposure, lane 1), but also diminished hyperosmotic EGFR phosphorylation (1 min of hyperosmotic exposure, lane 2). Yes knockdown blunts hyperosmotic EGFR/CD95 association and CD95 tyrosine phosphorylation, which otherwise (nonsense transfection) occur within 60 min of hyperosmotic exposure (lane 3). Hyperosmolarity induces within 3 h formation of DISC, as shown by the association of CD95 with FADD and Caspase 8. Yes knockdown prevents hyperosmotic DISC formation (lane 4) and CD95 translocation from the cytosol to the membrane (lane 5). D, hepatocytes were treated with nonsense (continuous line (E, q)) or Yes-antisense oligonucleotides (dotted line (», ᭛) and cultured for 4 days as described under "Experimental Procedures." Cells were then exposed to CD95L at the concentrations indicated, and after 12 h apoptosis was detected using the TUNEL assay. Cells were incubated with normoosmotic (305 mosM, open symbols) or hyperosmotic medium (405 mosM, closed symbols) 3 h prior to addition of CD95 ligand. In line with previous data on 24-h cultured untransfected hepatocytes (9), hyperosmotic exposure also sensitized 4-day cultured hepatocytes toward CD95L-induced apoptosis after transfection with the nonsense oligonucleotide. Yes knockdown not only abolished the hyperosmotic sensitization toward CD95L-induced apoptosis but also induced resistance toward CD95L-induced apoptosis in normoosmotically exposed hepatocytes. FIG. 8 . EGFR knockdown inhibits the hyperosmotic activation of the CD95 system. EGFR protein was knocked down as described under "Experimental Procedures." A, hepatocytes were cultured in cell culture medium (untreated control) or treated with nonsense or EGFR-antisense oligonucleotides for the time periods indicated. Total EGFR (ϳ170 kDa) was detected by Western blotting. Total CD95 amount (ϳ48 kDa) served as a loading control and to confirm specificity of EGFR-antisense oligonucleotides. EGFR-antisense led within 4 days to a marked decrease in total EGFR but not CD95 protein expression. B, in 4-day cultured hepatocytes, EGFR knockdown (lane 1) largely prevents hyperosmotic or EGF-induced EGFR phosphorylation (stimulation for 1 min, lane 2) and inhibits Erk activation (stimulation for 30 min, lane 3) in response to EGF (5 ng/ml) but not to hyperosmotic exposure. C, Yes, EGFR, and CD95 were immunoprecipitated as described under "Experimental Procedures" after the time periods indicated below. The immunoprecipitated CD95-samples were detected for EGFR association (ϳ170 kDa), for tyrosine phosphorylation (CD95-P-Tyr, ϳ48 kDa), for Fas-associated death domain (FADD, ϳ28 kDa) and caspase 8 (Casp8, ϳ54/55 kDa) association by Western blotting. Immunoprecipitated Yes and EGFR were detected for activating phosphorylation by Src family-Y 418 (P-Yes-Y 418 , ϳ62 kDa) or tyrosine phosphorylation (P-EGFR, ϳ170 kDa). Total Yes (ϳ62 kDa), total EGFR (ϳ170 kDa), and total CD95 (ϳ48 kDa) served as loading controls. The total CD95 amount (ϳ48 kDa) was also detected in membrane and cytosolic fractions obtained by ultracentrifugation as described under "Experimental Procedures." Representative blots from at least three independent experiments are shown. EGFR knockdown has no effect on the hyperosmolarityinduced Yes activation (detected after 1 min of hyperosmotic exposure, lane 1) but diminished hyperosmotic EGFR phosphorylation (1 min of hyperosmotic exposure, lane 2). EGFR knockdown blunts hyperosmotic EGFR/CD95 association and CD95 tyrosine phosphorylation, which otherwise (nonsense transfection) occur within 60 min of hyperosmotic exposure (lane 3). Hyperosmolarity induces within 3 h formation of DISC, as shown by the association of CD95 with FADD and caspase 8. EGFR knockdown prevents hyperosmotic DISC formation (lane 4). In line with previous studies (9, 10) , hyperosmotic exposure led within 3 h to an enrichment of CD95 in the membrane fraction in the control samples treated with nonsense oligonucleotides, whereas EGFR knockdown largely prevented CD95 membrane translocation (lane 5). D, hepatocytes were cultured for 4 days and treated with nonsense (continuous line (E, q)) or EGFR-antisense oligonucleotides (dotted line (▫, f)) as described under "Experimental Procedures." Cells were then exposed to CD95L at the concentrations indicated, and after 12 h apoptosis was detected using the TUNEL assay. Cells were incubated with normoosmotic (305 mosM, open symbols) or hyperosmotic medium (405 mosM, closed symbols) 3 h prior to addition of CD95 ligand. In line with previous data on 24 h cultured untransfected hepatocytes (9) , hyperosmotic exposure also sensitized 4 days cultured hepatocytes toward CD95L-induced apoptosis after transfection with the nonsense oligonucleotide. EGFR knockdown not only abolished the hyperosmotic sensitization toward CD95L-induced apoptosis but also induced resistance toward CD95L-induced apoptosis in normoosmotically exposed hepatocytes. normoosmotically exposed hepatocytes (Fig. 8D) . These findings demonstrate that EGFR is not only important for hyperosmotic CD95 activation but also for CD95 ligand-induced apoptosis in general. This is in line with previous data on an EGFR requirement for CD95 activation in response to CD95 ligand in hepatocytes (10) .
DISCUSSION
Hyperosmolarity Triggers Yes-mediated EGFR and JNK Activation-The Src kinase family comprises nine members, of which Src, Fyn, and Yes are ubiquitously expressed (for review see Refs. 13 and 14) . Multiple receptor pathways can couple with Src kinases, but Src family kinases are also activated in response to several forms of cell stress (for review see Refs. 13 and 14) , such as UV radiation (29) , hydrogen peroxide (30, 31) , or anisoosmolarity (11, 12, 32) . c-Src was implicated in both hepatocellular volume increase and decrease in response to hyper-or hypoosmolarity, respectively (8, 32) . In Chinese hamster ovary cells, however, hyperosmolarity induced Src inhibition, but not Fyn stimulation, which participates in the hyperosmotic phosphorylation of cortactin and reorganization of the cytoskeleton (12) . Hyperosmotic Fyn activation was also found in fibroblasts and triggers caveolin-1 phosphorylation (11) . As shown in the present study, mild hyperosmotic exposure of hepatocytes leads to an activation not only of Fyn but also of Yes and Lck. Hyperosmotic exposure of hepatocytes was recently shown to produce an instantaneous oxidative stress response (10), which may underlie hyperosmotic Yes activation. In line with this, inhibition of this oxidative stress-response by N-acetylcysteine (10) was found to prevent hyperosmotic activation of Yes but not of Fyn and Lck. This indicates that mechanisms distinct from oxidative stress trigger hyperosmotic Fyn and Lck activation, although, in several but not all (33) non-hepatic cell types, reactive oxygen species were shown to activate Fyn, Src, and Lck (15-17, 31, 34, 35) . Hyperosmolarity also triggers sustained JNK activation in an antioxidantsensitive way (10) , and as suggested by the data in the present study, hyperosmotic JNK activation apparently involves Yes activation as an upstream event. Hyperosmotic JNK activation was not sensitive to AG1478, indicating that hyperosmotic EGFR activation is not required for this effect. This contrasts findings with aortic endothelial cells, in which hydrogen peroxide-induced JNK activation was dependent upon EGFR transactivation (30) .
Little is known about specific effects exerted by Yes, although recent studies indicate that the SH4-Unique-SH3-SH2 domains dictate specificity in the signaling of c-Yes and c-Src, respectively (36) . Redundant functions of Src and Yes, respectively, are suggested by the finding that c-yes knockout mice display almost no overt phenotype (37) . As shown in the present study, Yes but not PP-2-, herbimycin-, or emodin-sensitive Src kinases triggers hyperosmotic activation of the EGFR. In line with this: (a) hyperosmolarity triggers a rapid antioxidant sensitive activation of Yes and its association with the EGFR, (b) various experimental maneuvers blocking hyperosmotic Yes activation or its association with the EGFR as well as Yes knockdown prevented hyperosmotic EGFR activation, and (c) inhibition of EGFR tyrosine kinase activity by AG1478 had no effect on hyperosmotic Yes activation and Yes/EGFR association, indicating that Yes acted upstream of EGFR activation. In line with this, inhibition of Yes/EGFR association but not of Yes activation by cAMP prevented hyperosmotic EGFR activation. Thus, the present data provide a novel role of Yes, namely transactivation of the EGFR (for review see Ref. 38) . As suggested by the Src kinase inhibitor profile and the Yes knockdown experiments, Src kinases distinct from Yes do not appreciably contribute to hyperosmotic EGFR activation in hepatocytes, although c-Src was shown to phosphorylate EGFR after activation of G-protein-coupled receptors (39, 40) , can directly bind to EGFR (41) , and was reported to activate EGFR in response to UV irradiation (29) . This situation, however, may be different when long term adaptations occur, which would explain why Yes knockout mice display almost no overt phenotype.
The mechanisms underlying the hyperosmolarity-induced Yes/EGFR association are unclear, however, Yes activation may be one prerequisite, because inhibition of hyperosmotic Yes activation by N-acetylcysteine or SU6656 abolished Yes/ EGFR association. In addition, Yes/EGFR association is inhibited by cAMP in an H89-sensitive way, suggestive of a negative regulation by protein kinase A. JNKs apparently play no role in the Yes/EGFR association, because Yes/EGFR association precedes hyperosmotic JNK activation and is insensitive to JNK inhibition.
Role of Yes in the Hyperosmotic Activation of the CD95 System-EGFR-derived signals are known to exert proliferative and anti-apoptotic effects (38) , however, recent evidence also suggests an important role of EGFR in triggering CD95-dependent hepatocyte apoptosis in response to hyperosmolarity, CD95L addition or toxic bile acids (10, 26) . All these maneuvers transactivate EGFR and trigger its association with CD95 with FIG. 9 . Activation of the CD95 system by hyperosmolarity in rat hepatocytes. The scheme summarizes our current view on the events leading to hyperosmotic activation of the CD95 system. Hyperosmolarity leads to an almost instantaneous generation of reactive oxygen species (ROS), which in turn results in an activation of the Src kinases family member Yes. Apart from Yes, Lck 56 or Fyn also became activated upon hyperosmotic exposure but in an ROS-independent way. Activated Yes then associates with EGFR, which becomes tyrosinephosphorylated and activated probably by Yes kinase activity. In addition, Yes triggers hyperosmotic JNK activation. Activated EGFR then associates with CD95, which requires the JNK signal. CD95 becomes tyrosine-phosphorylated by EGFR tyrosine kinase activity and translocates to the plasma membrane, and formation of DISC occurs. For further details see text.
subsequent EGFR-catalyzed CD95 tyrosine phosphorylation, which acts as a signal for CD95 membrane trafficking and DISC formation. The importance of EGFR in the hyperosmotic activation of the CD95 system is corroborated by the present finding that EGFR knockdown inhibits hyperosmotic CD95 activation and prevents apoptosis induction in response to CD95 ligand.
The present study also identifies hyperosmotic Yes activation as an important upstream component in triggering hyperosmotic CD95 activation through activation of both the EGFR and JNK. Yes knockdown, as well as all maneuvers employed to inhibit hyperosmotic Yes activation or Yes/EGFR association, such as N-acetylcysteine, SU6656, or cAMP not only blocked hyperosmotic EGFR activation but also hyperosmotic CD95 membrane trafficking and activation, whereas other inhibitors of other Src kinases (PP-2, herbimycin A, and emodin) were ineffective. As discussed above, hyperosmotic Yes activation may also trigger hyperosmotic JNK activation, which is required for the hyperosmotic EGFR-CD95 interaction, because JNK inhibition prevented EGFR from interacting with CD95 thereby preventing hyperosmotic CD95 activation (10, 26) . In line with this, recent data identified the EGFR as a target of JNK-induced serine/threonine phosphorylation (42, 43) . One consequence of EGFR-CD95 interaction is a rapid CD95 tyrosine phosphorylation, which is probably achieved through EGFR tyrosine kinase activity in view of the AG1478 sensitivity of the process. Interestingly, hyperosmotic Yes/ EGFR association precedes EGFR/CD95 association and no Yes was coimmunoprecipitated together CD95. This may indicate that Yes dissociates from EGFR prior to EGFR/CD95 association. In contrast to the cAMP sensitivity of the hyperosmotic Yes/EGFR association, which triggers EGFR activation, the subsequent EGFR/CD95 association is not sensitive to cAMP (27) . Thus, the anti-apoptotic effect of cAMP in hepatocytes (27, 44) may reside not only on a protein kinase A-mediated Ser/Thr phosphorylation of CD95 (27) but probably more important in a failure of activated Yes to associate with EGFR and to trigger EGFR activation. Our current view on the sequence of events leading to hyperosmotic CD95 activation is schematically depicted in Fig. 9 . In line with an important role of Yes in the hyperosmotic activation of the CD95 system in hepatocytes may also be the recent observation that Shiga toxin-induced cell death in the human renal tubular cell line ACNH is accompanied by a Shiga toxin-triggered Yes activation (45) .
Apart from Yes, Fyn and Lck were also activated in response to hyperosmolarity. The functional consequences of this are unknown, however, the present inhibitor experiments suggest that these Src kinase family members are not involved in the hyperosmotic activation of the CD95 system in hepatocytes. In line with this, Lck is not required for execution of apoptosis after CD95 ligation in T-lymphocytes (46), although Lck is required for induction of CD95 ligand (47) . On the other hand studies with Fyn-deficient mice suggested an important role of Fyn in CD95 signal transduction (48) . Because Src family kinase signaling toward mitogen-activated protein kinases and phosphatidylinositol 3-kinase is well established (for review see Ref. 13 ), a modulatory role of the apoptotic program by these kinases appears feasible. Further studies are required to settle the functional consequences of hyperosmotic activation of Lck and Fyn.
